Porterhouse Medical, a global strategic scientific communications agency, has expanded its US team with the appointment of Jennifer Stewart as a Medical Director.
Jennifer brings extensive expertise across scientific publications, medical affairs and multiple therapeutic areas including rare diseases, gene therapy, oncology, immunology, neurology and cardio-renal medicine.
Jennifer has a strong academic background and over a decade of experience supporting biopharmaceutical companies of all sizes. Her career includes senior roles at IPG Health Med Comms, where she advanced from Scientific Medical Writer to Associate Medical Director, as well as editorial leadership positions at Human Gene Therapy Clinical Development and the Gene Therapy Program at the University of Pennsylvania.
Micheal Tague, President of Porterhouse Medical US, commented: “We are thrilled to welcome Jennifer to the team. Her appointment reflects both the growth of our US operations and the increasing demand for expertise in complex and fast-moving therapeutic areas.
“Jennifer’s deep experience across publications and medical affairs makes her a valuable addition to our agency as we continue to support our clients in communicating cutting-edge science.”